Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) — Cash Flow Reinvestment Rate
Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥18.35 Million (capex CN¥18.35 Million ) from operating cash flow of CN¥502.01 Million. Check Nanjing King-friend Biochemical Pharmace (603707) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Nanjing King-friend Biochemical Pharmaceutical Co Ltd across 9 annual periods. Explore how well can Nanjing King-friend Biochemical Pharmace service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Nanjing King-friend Biochemical Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Nanjing King-friend Biochemical Pharmace worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | CN¥758.44 Million | CN¥1.18 Billion | CN¥560.15 Million | ▲ +5.7% |
| 2024 | 0.61x | CN¥910.73 Million | CN¥1.50 Billion | CN¥506.82 Million | ▼ -37.9% |
| 2023 | 0.98x | CN¥1.58 Billion | CN¥1.62 Billion | CN¥419.07 Million | ▼ -33.2% |
| 2022 | 1.46x | CN¥870.57 Million | CN¥595.45 Million | CN¥470.08 Million | ▼ -4.9% |
| 2021 | 1.54x | CN¥1.05 Billion | CN¥683.63 Million | CN¥440.76 Million | ▼ -73.4% |
| 2018 | 5.79x | CN¥361.01 Million | CN¥62.37 Million | CN¥82.76 Million | ▲ +3095.2% |
| 2015 | 0.18x | CN¥24.87 Million | CN¥137.28 Million | CN¥24.87 Million | ▲ +10.2% |
| 2014 | 0.16x | CN¥29.40 Million | CN¥178.74 Million | CN¥29.40 Million | ▼ -48.5% |
| 2013 | 0.32x | CN¥61.96 Million | CN¥193.91 Million | CN¥61.96 Million | — |